Docket

36848

Britton Low v. Pfizer Canada Inc., et al.

(British Columbia) (Civil) (By Leave)

Judgments on applications for leave to appeal are rendered by the Court, but are not necessarily unanimous.

Proceedings
Date Proceeding Filed By
(if applicable)
2016-06-14 Close file on Leave
2016-06-10 Copy of formal judgment sent to Registrar of the Court of Appeal and all parties
2016-06-10 Judgment on leave sent to the parties
2016-06-09 Judgment of the Court on the application for leave to appeal, The motion for an extension of time to serve and file the motion for leave to intervene is dismissed. The application for leave to appeal from the judgment of the Court of Appeal for British Columbia (Vancouver), Number CA42139, 2015 BCCA 506, dated December 8, 2015, is dismissed with costs.
Dismissed, with costs
2016-06-09 Decision on motion to extend time, see judgment on leave application
Dismissed
2016-05-09 All materials on application for leave submitted to the Judges, Abe Ka Br
2016-05-09 Submission of motion to extend time, Abe Ka Br
2016-05-09 Submission of motion for leave to intervene, Abe Ka Br
2016-04-25 Reply to the motion for leave to intervene., (Letter Form), Completed on: 2016-04-25, (Electronic version filed on 2016-04-27) Canadian Generic Pharmaceutical Association
2016-04-18 Response to the motion for leave to intervene, (Letter Form), Completed on: 2016-04-18, (Electronic version filed on 2016-04-18) Pfizer Canada Inc.
2016-04-18 Response to the motion for leave to intervene, (Letter Form), Completed on: 2016-04-18, (Electronic version filed on 2016-04-18) Britton Low
2016-04-15 Book of authorities, (Book Form), (2 volumes), (Electronic version filed on 2016-04-15) Canadian Generic Pharmaceutical Association
2016-04-07 Motion to extend time, (Book Form), (Included in the motion for leave to intervene), Completed on: 2016-04-07, (Electronic version filed on 2016-04-08) Canadian Generic Pharmaceutical Association
2016-04-07 Motion for leave to intervene, (Book Form), only submit 2 copies. 4 copies missing. All the copies received 2016-04-08., Completed on: 2016-04-07, (Electronic version filed on 2016-04-08) Canadian Generic Pharmaceutical Association
2016-03-21 Applicant's reply to respondent's argument, (Book Form), Completed on: 2016-03-21, (Electronic version filed on 2016-03-21) Britton Low
2016-03-11 Book of authorities, (Book Form) Pfizer Canada Inc.
2016-03-11 Certificate (on limitations to public access), (Letter Form), (Electronic version filed on 2016-03-14) Pfizer Canada Inc.
2016-03-11 Notice of name, (Letter Form), Pfizer Research and Development Company N.V./S.A., (Electronic version filed on 2016-03-14) Pfizer Canada Inc.
2016-03-11 Notice of name, (Letter Form), Pfizer Ireland Pharmaceuticals, (Electronic version filed on 2016-03-14) Pfizer Canada Inc.
2016-03-11 Notice of name, (Letter Form), Pfizer Inc., (Electronic version filed on 2016-03-14) Pfizer Canada Inc.
2016-03-11 Notice of name, (Letter Form), Pfizer Canada Inc., (Electronic version filed on 2016-03-14) Pfizer Canada Inc.
2016-03-11 Respondent's response on the application for leave to appeal, (Book Form), Completed on: 2016-03-11, (Electronic version filed on 2016-03-14) Pfizer Canada Inc.
2016-02-18 Correspondence received from, (Letter Form), Estimated time to file the Final CA Order 2016-04-20. Britton Low
2016-02-11 Letter acknowledging receipt of an incomplete application for leave to appeal and without formal Court of Appeal order, file opened 2016-02-11.
2016-02-08 Book of authorities, (Book Form), (3 volumes) Britton Low
2016-02-08 Certificate (on limitations to public access), (Letter Form), (Electronic version filed on 2016-02-16) Britton Low
2016-02-08 Application for leave to appeal, (Book Form), CA Order missing. Expected 2016-04-20. Received 2016-03-14., Completed on: 2016-03-15, (Electronic version filed on 2016-02-16) Britton Low